Related Experiment Videos
In utero nephropathy, Denys-Drash syndrome and Potter phenotype
E F Maalouf1, J Ferguson, V van Heyningen
1Department of Paediatrics and Neonatal Medicine, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
Pediatric Nephrology (Berlin, Germany)
|September 24, 1998
Summary
A novel WT1 gene mutation caused severe Denys-Drash syndrome in a newborn with kidney failure and Potter phenotype. This finding suggests further investigation of this mutation in similar cases.
Area of Science:
- Genetics
- Pediatric Nephrology
- Developmental Biology
Background:
- Denys-Drash syndrome (DRS) is a rare genetic disorder characterized by nephropathy, Wilms tumor, and disorders of sex development.
- Early diagnosis and understanding the genetic basis of DRS are crucial for patient management and prognosis.
- The Wilms tumor 1 (WT1) gene is a key regulator in kidney and gonad development, and mutations are implicated in DRS.
Observation:
- This report details an unusual case of DRS in a neonate.
- The infant presented with end-stage renal failure originating before birth and Potter phenotype.
- The presentation was unusually severe and early-onset.
Findings:
- DNA analysis identified a novel missense mutation in the WT1 gene, specifically at arginine 394 within zinc finger 3.
- This specific mutation (c.1181G>A; p.Arg394His) has not been previously reported in association with Denys-Drash syndrome.
- The identified mutation is predicted to impact the DNA-binding function of the WT1 protein.
Implications:
- The novel WT1 mutation may explain the severe and antenatal presentation of Denys-Drash syndrome in this infant.
- This discovery highlights the genetic heterogeneity of DRS and the potential for novel mutations to cause severe phenotypes.
- Further research into this specific WT1 mutation could improve diagnostic strategies for infants with Potter phenotype and unexplained renal failure.